The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Walder Wyss Ltd

Walder Wyss Overview PDF Walder Wyss Overview PDF
Work +41 58 658 58 58
Fax +41 58 658 59 59

Show all Press releases

Metall Zug (SIX: METN) acquires majority holding in Haag-Streit Holding AG

January 2018

The Metall Zug Group has signed an agreement to acquire 70% of Haag-Streit Holding AG, based in Köniz, Switzerland. The transaction is expected to be consummated during the first quarter of 2018. 

Haag-Streit is a leading medical technology company in the fields of ophthalmology (diagnostics & surgical microscopy), pulmonology and optics. The Haag-Streit Group comprises more than twenty companies in Europe, America and the Far East. Its head office is in Köniz, Switzerland, and it has additional production facilities in Switzer-land, Germany, the United Kingdom and the USA. In the 2016 financial year the company and its approximately 900 employees generated sales of about CHF 200 million. As the Metall Zug Group’s fourth business unit, Haag-Streit will continue to maintain an independent market presence with its own autonomous brand. The Haag-Streit Group generated operating profit (EBITDA) of some CHF 30 million in the 2016 financial year. Its EBITDA margin was nearly 16%. 

Metall Zug, an industrial group of companies headquartered in Zug, comprises three Business Units and has a workforce of around 4,000. The holding company Metall Zug AG is listed in the Swiss Reporting Standard of SIX Swiss Exchange.

Walder Wyss Ltd has been advising Metall Zug as Lead Counsel on all legal aspects of the transaction. The lead is being led by Alex Nikitine(Partner, Corporate/M&A) and further includes Valentin Wiesner(Associate, Corporate/M&A), Hugh Reeves (Associate, IP/IT), Andreas Wildi (Partner, Life Sciences, Regulatory), AndrĂ© Kuhn (Associate, Real Estate), Lukas Wyss (Partner, Banking & Finance), Marion Bähler (Associate, Corporate/M&A), Fabian Looser (Associate, Employment), Annemarie Lagger (Associate, IP/IT) and Daniel Zimmerli (Managing Associate, Anti-Trust).

Legal Developments by:
Walder Wyss

  • 17 February 2017: Auris Medical's Public Equity Offering

    Auris Medical Holding AG (NASDAQ: EARS) issued and priced its public offering of 10,000,000 common shares and 10,000,000 warrants, each warrant entitling its holder to purchase 0.70 of a common share.  The common shares and warrants are being sold in units comprised of one common share and one warrant at the public offering price of USD 1.00 per unit. The warrants will be immediately exercisable at a price of USD 1.20 per common share and are exercisable for five years. In connection with the offering, the Company has granted the underwriter a 30-day option to purchase up to 1,500,000 additional common shares and/or 1,500,000 additional warrants at the public offering price less underwriting discounts. The offering is expected to close on or about February 21, 2017, subject to customary closing conditions. Roth Capital Partners is acting as sole book-running manager in the offering. Maxim Group LLC is acting as a financial advisor in the offering.
    - Walder Wyss Ltd

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to